S24-14

N/A

Report date: 2024/09/20 14:48:02
NME

Base Information

Drug NameS24-14
Drug Alias NameS24-14S-24-14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteoclasts inhibitors
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangdong Second Hospital Of Traditional Chinese MedicineSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Second Hospital Of Traditional Chinese MedicineSun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A